Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Key-properties outlook of novel microparticulate platforms for bone therapeutic targeting
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-B-003-Tuesday
- By: BETTENCOURT, Ana (Faculty of Pharmacy, Universidade de Lisboa, Ciencias Toxicologicas e Bromatologicas, Lisboa, Portugal)
- Co-author(s): Ana Bettencourt: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
Ines Santos-Ferreira: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
Judith Kikhney: Biofilmcenter, Deutsches Herzzentrum Berlin, Charité – Universitätsmedizin Berlin, Germany, Germany
Isabel Ribeiro: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
Lidia Gonçalves: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal
Andrej Trampuz: Center for Musculoskeletal Surgery, Charité – Universitätsmedizin Berlin, Germany
Annette Moter: Biofilmcenter, Deutsches Herzzentrum Berlin, Charité – Universitätsmedizin Berlin, Germany, Germany
António Almeida: Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal - Abstract:
Backgrounds
Conventionally, complicated bone infections caused by Gram-positive bacteria are treated with vancomycin. However, emergence of resistant Staphylococci to vancomycin led to the increased use of daptomycin. Nevertheless, in severe bone infections, daptomycin efficacy is often limited, due to insufficient drug bioavailability at the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023